Abstract
HIV-1 has resulted in a devastating AIDS pandemic. An effective HIV/AIDS vaccine that can be used to either, prevent HIV infection, control infection or prevent progression of the disease to AIDS is needed. In this review we discuss the use of Mycobacterium bovis BCG, the tuberculosis vaccine, as a vaccine vector for an HIV vaccine. Numerous features make BCG an attractive vehicle to deliver HIV antigens. It has a good safety profile, elicits long-lasting cellular immune responses and in addition manufacturing costs are affordable, a necessary consideration for developing countries. In this review we discuss the numerous factors that influence generation of a genetically stable recombinant BCG vaccine for HIV.
Keywords: Recombinant BCG, Mycobacterium bovis BCG, HIV, vaccine vector
Current HIV Research
Title: Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector
Volume: 8 Issue: 4
Author(s): Rosamund Chapman, Gerald Chege, Enid Shephard, Helen Stutz and Anna-Lise Williamson
Affiliation:
Keywords: Recombinant BCG, Mycobacterium bovis BCG, HIV, vaccine vector
Abstract: HIV-1 has resulted in a devastating AIDS pandemic. An effective HIV/AIDS vaccine that can be used to either, prevent HIV infection, control infection or prevent progression of the disease to AIDS is needed. In this review we discuss the use of Mycobacterium bovis BCG, the tuberculosis vaccine, as a vaccine vector for an HIV vaccine. Numerous features make BCG an attractive vehicle to deliver HIV antigens. It has a good safety profile, elicits long-lasting cellular immune responses and in addition manufacturing costs are affordable, a necessary consideration for developing countries. In this review we discuss the numerous factors that influence generation of a genetically stable recombinant BCG vaccine for HIV.
Export Options
About this article
Cite this article as:
Chapman Rosamund, Chege Gerald, Shephard Enid, Stutz Helen and Williamson Anna-Lise, Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector, Current HIV Research 2010; 8 (4) . https://dx.doi.org/10.2174/157016210791208686
DOI https://dx.doi.org/10.2174/157016210791208686 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small Heat Shock Proteins (sHSPs) As Potential Drug Targets
Current Pharmaceutical Biotechnology Phosphoserine Aminotransferase has Conserved Active Site from Microbes to Higher Eukaryotes with Minor Deviations
Protein & Peptide Letters Αlpha-2 Adrenergic and Opioids Receptors Participation in Mice Gastroprotection of Abelmoschus esculentus Lectin
Current Pharmaceutical Design Recent Advances of Fluorescent Technologies for Drug Discovery and Development
Current Pharmaceutical Design Editorial
Central Nervous System Agents in Medicinal Chemistry The Apoptosis Mechanism of Epirubicin Combined with BCG on Human Bladder Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Recent Developments in Pleuromutilin Derivatives: A Promising Class Against Bacterial Respiratory Disease
Current Respiratory Medicine Reviews Synthesis, Reactions and Biological Evaluation of 3-Amino-6- (subs.)thieno[2,3-b]pyridine-2-carbohydrazides
Current Bioactive Compounds Coumarin-Oxadiazole Derivatives: Synthesis and Pharmacological Properties
Mini-Reviews in Organic Chemistry Modern Drug Discovery Technologies: Opportunities and Challenges in Lead Discovery
Combinatorial Chemistry & High Throughput Screening Review of the Syntheses and Activities of Some Sulfur-Containing Drugs
Current Organic Synthesis Quinolone-Based Drugs Against Toxoplasma gondii and Plasmodium spp
Current Drug Targets - Infectious Disorders Drug Targets in Mycobacterial Sulfur Metabolism
Infectious Disorders - Drug Targets Ascorbic Acid and Gene Expression: Another Example of Regulation of Gene Expression by Small Molecules?
Current Genomics Synthesis of Adamantane Aminoethers with Antitubercular Potential
Medicinal Chemistry Impurity Profiling-A Significant Approach in Pharmaceuticals
Current Pharmaceutical Analysis Novel Small-Molecule Inhibitors of Arylamine N-Acetyltransferases: Drug Discovery by High Throughput Screening
Combinatorial Chemistry & High Throughput Screening Histopathological Scores for Tissue-Engineered, Repaired and Degenerated Tendon: A Systematic Review of the Literature
Current Stem Cell Research & Therapy The Balancing Act between Colonisers and Inflammation: T regulatory and TH17 Cells in Mucosal Immunity during Otitis Media
Current Immunology Reviews (Discontinued) Quality by Design Approach for Development and Optimization of Rifampicin Loaded Bovine Serum Albumin Nanoparticles and Characterization
Current Drug Delivery